GSP Crop Science
Bidding Information
- Opens
- Mar 16, 2026
- Closes
- Mar 18, 2026
- Listing Date
- Mar 24, 2026
Company Description
GSP Crop Science Ltd IPO – Complete Overview
GSP Crop Science Ltd IPO is a mainboard IPO aiming to raise around ₹400 crore. The issue consists of a mix of fresh issue and offer for sale, where the company plans to use proceeds mainly for debt repayment and general corporate purposes.
Company Overview
GSP Crop Science Ltd is an Ahmedabad-based agrochemical company engaged in the development and manufacturing of crop protection products such as insecticides, herbicides, fungicides, and plant growth regulators.
The company has a strong presence in both domestic and international markets and focuses on improving agricultural productivity through innovative solutions. Over the years, it has built a diversified product portfolio and expanded its global footprint.
IPO Objectives
The company plans to utilize the IPO proceeds for the following purposes:
Repayment or prepayment of existing borrowings
Funding working capital requirements
General corporate purposes
This indicates a focus on improving the balance sheet and supporting future growth.
Financial Performance
GSP Crop Science has shown steady growth in revenue and profitability over the years, reflecting operational stability.
For the latest financial period:
Revenue: approximately ₹1,418 crore
Profit After Tax (PAT): approximately ₹75.59 crore
EBITDA: approximately ₹145.08 crore
Recent growth trends indicate strong improvement:
Revenue increased to around ₹1,688 crore (annualised FY25)
Profit After Tax reached approximately ₹162 crore
EBITDA improved to around ₹277 crore
For the six months ending September 2025:
Revenue: approximately ₹844 crore
Profit: approximately ₹82.7 crore
The company maintains healthy profitability margins, with a PAT margin close to 9–10%, along with improving operational efficiency.
Strengths
GSP Crop Science stands out due to its diversified agrochemical product portfolio and strong R&D capabilities. The company has built a consistent presence in both domestic and export markets, which helps reduce dependency on a single geography.
Its improving financial performance, especially growth in profitability and EBITDA margins, indicates better operational efficiency.
Risks
The business is dependent on the agriculture sector, which is affected by monsoon conditions and government policies.
The agrochemical industry is highly competitive, with pressure on pricing and margins.
Also, a portion of IPO proceeds is being used for debt repayment, indicating existing leverage.
Check Your Allotment Status
Verify if shares have been allocated to your application
Frequently Asked Questions
Common questions about GSP Crop Science IPO
What is the current GMP of GSP Crop Science IPO?
The current Grey Market Premium (GMP) of GSP Crop Science IPO is ₹320. This indicates an expected listing gain of approximately 0.00% over the issue price of ₹320. GMP reflects unofficial market sentiment and can fluctuate based on demand and market conditions.
When is the allotment date for GSP Crop Science IPO?
The allotment date for GSP Crop Science IPO is Mar 23, 2026. The IPO listing is scheduled for Mar 24, 2026. You can check your allotment status on the registrar's website once the allotment is finalized.
Is GSP Crop Science IPO good for long-term investment?
GSP Crop Science IPO shows a current GMP of ₹320 with an expected listing gain of 0.00%. However, investment decisions should be based on your risk profile, company fundamentals, industry outlook, and financial goals. We recommend reviewing the company's DRHP, financial statements, and competitive position. Always consult with a SEBI registered financial advisor before making investment decisions.
What is the issue price and lot size of GSP Crop Science IPO?
GSP Crop Science IPO has an issue price of ₹320 per share with a lot size of 46 shares. The total issue size is ₹400 crores. This means the minimum investment required is ₹14,720.
Related IPOs You May Like
Explore similar upcoming and active IPOs